Purification of Lipid-Based Nanoparticles with the qEV Platform
LNP Purification, Without Compromise
Lipid-based nanoparticles are driving innovation in drug delivery, and require gentle, yet efficient, purification for therapeutic development.
The qEV platform harnesses SEC+ to:
Isolate LNPs from free lipids, proteins, and impurities
Preserve particle integrity with gentle separation
Scale easily from research to therapeutic development
Scalable Solutions
Scale LNP purification with qEV100
- Isolate sample volumes up to 100 mL
- Ideal for formulation batches or scaling up LNP production
- Available in resin series options: 20 nm, 35 nm, and 70 nm
- Compatible with the qEV Zenco for automation
Automate your workflow with the qEV Zenco
- Streamline LNP purification at 2–400 mL scale
- Live monitoring of UV trace, pH, conductivity, flow rate, and pressure helps identify purified collection volume and maximise reproducibility
- Programmable workflows enable running, flushing, cleaning columns between cycles
Prioritise Purity
Isolating lipid-based nanoparticles at high yield doesn’t have to compromise purity.
Our 20 nm and 35 nm resin series delivers maximum recovery of particles, with superior purity compared to TFF - all while preserving particle integrity.
qEV Resin Series
Particle Size Range
Best For
20 nm
20 nm+
Maximising yield
35 nm
35 nm+
Yield and purity balance
70 nm
70 nm+
Maximising purity
Let's support you to therapeutic sooner
As you move from research to therapeutic development, navigating cGMP regulations is critical. Our platform is built to support this transition by offering:
cGMP-ready qEV columns
qEV Zenco Pro system with cGMP-ready option
21 CFR Part 11–compliant software
